Gynaecological Malignant Tumours at Imo State University Teaching Hospital Orlu South Eastern Nigeria

JC Umeobika, LC Ikeako, CT Ezenyeaku, UI Ezebialu, EC Ojiyi


Background: Gynaecological malignancies are important component of reproductive health and contribute significantly to morbidity and mortality in women. They have a world-wide distribution which varies from region to region.

Objective: To determine the frequency and pattern of gynaecological malignancies at Imo State University Teaching Hospital, Orlu South Eastern Nigeria.

Methods: A retrospective analysis of all patients with histologically confirmed genital tract malignancies at the Department of Obstetrics and Gynaecology of Imo State  University Teaching Hospital Orlu in South Eastern Nigeria from 1st of January, 2004 to 31st of December, 2013.

Results: Out of 218 cases of gynaecological malignancies, 131 (60.1%) were cervical cancer, 45(20.6%) were ovarian cancer, 23 (10.6%) were cancers of the corpus uteri, 12(5.5%) were choriocarcinoma, 11(5.1%) were endometrial cancers while vaginal cancer accounted for only 1 (0.5%). The age distribution was mainly within the 30-69 age range 184 (84.4%) with a peak occurrence at the 40-49 age group 75 (34.4%). The incidence of cervical and ovarian cancers peaked at 40-49 years with 52 (39.7%) and 11 (24.5%) of the individual cancers respectively. The gynaecological malignancies appeared to occur less at the extremes of age (<20 years and ≥70 years).

Conclusion: Cervical cancer was the commonest type of gynaecological malignancy in this study, despite the fact that it is the most preventable of all the gynaecological malignancies and a major cause of morbidity and mortality in Nigeria. Establishment of a nationwide health insurance scheme that covers cervical cancer screening and human papilloma virus (HPV) vaccination augmented by health education and awareness creation is very vital towards curbing this ugly trend.

Full Text:



Yakasai IA, Ugwu EA, Otubu J. Gynaecological malignancies in Aminu Kano Teaching Hospital, Kano: A 3 year review. Niger J. Clin Pract. 2013; 16: 63-66

Kyari O, Nggada H, Mairiga A. Malignant tumours of the female genital tract in North Eastern Nigeria. East Afr Med J. 2004; 81 (3): 142-145

Nkyekyer K. Patten of gynaecological cancers in Ghana. East Afr. Med J. 2000; 77 (10):534-538

Stewart BW, Kleihues P. Cancers of female reproductive tract. In : World cancer report Lyon: IARC Press: 2003

Franco EL, Franco ED, Ferenczy A. Cervical cancer: epidemiology, prevention and the role of human papilloma virus infection. Canadian Med Assoc J. 2001; 164: 1017-1025

Iyaiya MA, Aboyeji PA, Buhari MO. Cancer of the cervix in Ilorin, Nigeria. West Afr J Med. 2004; 23:319-322

Rogo KO, Omany J, Oyango JN, Ojwang SB, Stendah L. Carcinoma of the cervix in the Africa Setting. Int J Gynaecol Obstet. 1990; 33:249-255

Ojiyi EC, Dike EI, Nzewuihe ACE, Ejikem EC. Epidemiology of cervical cancer at the Anambra State University Teaching Hospital, Awka. Trop J Med Heal Sc. 2012; 10-13.

Denny L. The prevention of cancer in developing countries. BJOG. 2005; 112(9): 1204-1212

Agosti JM, Goldie SJ. Introducing HPV vaccine in developing countries- key challenges and issues. N Engl J Med. 2007; 356 (19): 1908-1910

Ali F, Kuelker R, Wassie B. Understanding cervical cancer in the context of developing countries. Ann Trop Med Public Health. 2012; 5 (1): 3-15

Ferlay J, Shin HR, Bray F. GLOBOCAN 2008 V 1.2, cancer incidence and mortality worldwide: IARC cancer Base No 10 (Internet). Lyon, France: International Agency for Research on cancer, 2010. Available from

National cancer intelligence Network (NCIN). Cancer incidence, mortality and survival for UK. Cancer e-Atlas guide, 2012. Available at http/¬ (Accessed July 20, 2017).

Trent cancer Registry. Profile of cervical cancer in England. Incidence, mortality and survival. Sheffield: Trent cancer Registry/NHS cancer screening Programmes 2012. Available at (Accessed July 10 2017).

National cancer Intelligence Network (NCIN). One, five and ten year cancer prevalence, London: 2010. Available at (Accessed July 15 2017).

Babarinsa IA, Akang EEU, Adewole IF. Pattern of gynaecological malignancies at the Ibadan cancer Registry (1976-1995). Nig Qt J Hosp Med. 1998; 8:103-106

Chamberlain G, Fairly DH. Malignant gynaecology conditions. In: chamberlain G (ed). Lecture notes on obstetrics and Gynaecology. Oxford: Blackwell Science Ltd; 1999:46-50.

Jamal S, Mamoon N, Mushtaq S, Luqman M, Moghal S. The pattern of gynaecological malignancies in 968 cases from Pakistan. Ann Saudi Med. 2006; 26:382-384.

Airede LR, Malami SA. A five-year review of female genital tract malignancies in Sokoto North-Western Nigeria. Mary Slessor Journal of Medicine. 2005; 5:51-56

Nwosu SO, Anya SE. Malignancies of the female genital tract at the University of Port-Harcourt Teaching Hospital. Niger postgrad Med J. 2004; 11:107-109

Ugwu EO, Iferikigwe ES, Okeke TC, Ugwu AO, Okezie OA, Agu PU. Pattern of gynaecological cancers in University of Nigeria Teaching Hospital, Enugu, South-Eastern Nigeria. Niger J Med. 2011:20:266-269

Kyari O, Ngadda H, Mairiga A, Malignant tumours of female genital tract in North-Eastern Nigeria. East Afr Med J. 2004; 81:142-145

Briggs ND, Katchy KC. Pattern of primary gynaecological malignancies as seen in a tertiary hospital situated in the Rivers state of Nigeria. Int J Gynecol Obstet 1990; 31:157-161

Okeke TC, Onah N, Ikeako LC, Ezenyeaku CCT. The frequency and pattern of female Genital tract Malignancies at the University of Nigeria

Teaching Hospital, Enugu, Nigeria. Ann Med Health Sci Res. 2013; 3(3): 345-348

Klufio CA. Epithelial ovarian carcinoma. In: Comprehensive Gynaecology in the Tropics. Kwuwukume EY, Emuveyan EE (eds). Graphic Packaging Ltd, Accra 2005; 449-471.

WHO/ICO. Information center on HPV and cervical cancer (HPV Information Center) Human Papilloma virus and related cancers in worlds Summary Report 2010. Available at: (Accessed Nov. 15 2012)

Jamal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61 (2): 69-90


  • There are currently no refbacks.